Back to today’s briefing

Story perspectives

Gene Therapy Market to Surge to $38.33 Billion by 2030

1/29/2025

25 4

Summary

Story summary

The global gene therapy market is set to skyrocket from $9.42 billion in 2024 to an astounding $38.33 billion by 2030, fueled by breakthroughs in genetic engineering and rising healthcare investments. North America takes the lead, with Europe and Asia-Pacific also making significant strides. Major players like Regenxbio, Novartis, and Bluebird Bio are at the forefront of this transformative industry.

1 of 1

Story summary

The global gene therapy market is set to skyrocket from $9.42 billion in 2024 to an astounding $38.33 billion by 2030, fueled by breakthroughs in genetic engineering and rising healthcare investments. North America takes the lead, with Europe and Asia-Pacific also making significant strides. Major players like Regenxbio, Novartis, and Bluebird Bio are at the forefront of this transformative industry.